Novartis skin drug helps patients with chronic hives

ZURICH (Reuters) - Swiss drugmaker Novartis said its drug omalizumab significantly improved itch in patients with a severe form of hives, according to a late-stage study.

http://feedproxy.google.com/~r/reuters/healthNews/~3/JwynxS6_jFY/story01.htm

Source: Reuters: Health - June 26, 2013 Category: Consumer Health News Tags: healthNews Source Type: news